A New Model for Cancer Research Funding: Why Curefundr Is Changing the Equation

Healthcare leaders understand the urgency of advancing cancer care, yet progress often depends on systems that move too slowly, creating a disconnect between scientific potential and real-world impact. While platforms like Kickstarter have shown how quickly new products can be funded and launched, cancer research funding has not kept pace with that level of efficiency. Curefundr, founded by Scarlett Cohan, introduces a new model designed to accelerate progress and reduce delays that cost lives.

A Personal Wake-Up Call

Cohan’s mission began with a deeply personal moment. At her middle school graduation, a close family member was absent while battling advanced cancer and complications from chemotherapy. That empty seat became a defining image that stayed with her. It reflected not only personal loss but also the broader reality of missed milestones experienced by families facing cancer.

As she reflected on that moment, she recognized a troubling contradiction. The United States is filled with motivated and brilliant scientists, yet funding cuts to university research and the National Cancer Institute threaten their ability to act. From that realization came a commitment that future milestones in her life would not be marked by absence due to a disease that science has the potential to confront more effectively.

The Power of Crowdfunding in Healthcare

That commitment began to take shape during the COVID pandemic. While volunteering with the “Get a Mask Stat” initiative, Cohan helped organize the rapid distribution of N-95 masks to physicians across Los Angeles and the country, turning urgency into coordinated action. In just a few weeks, the team established seven distribution centers and delivered masks to over 6,000 physicians.

The effort relied on crowdfunding to raise money quickly, securely, and efficiently, demonstrating how collective action could meet urgent healthcare needs at scale. For Cohan, it became clear that this same approach could be applied to cancer research financing, where time is just as critical.

Rethinking Cancer Research Financing

Building on that experience, Curefundr applies crowdfunding directly to cancer research, offering a focused alternative to traditional cancer research grants and funding systems. As the first platform devoted exclusively to this purpose, it simplifies access to support for researchers while increasing transparency for donors.

Through Curefundr, researchers receive funds instantly and securely, directly to their bank accounts, allowing them to begin work without unnecessary delays. They are not required to complete lengthy 40-page grant applications or wait through extended approval cycles, and they do not need to reach 100 percent of their funding goal to access support, removing a common barrier seen on other platforms.

At the same time, the platform introduces accountability through a board of physician-researchers who review projects, and donors can clearly see where their money is going. Unlike traditional cancer research organizations, funds go directly to researchers rather than administrative layers, creating a more direct connection between contribution and impact.

Overcoming Barriers to Progress

Developing a secure and user-friendly platform required careful iteration, as the Curefundr team worked through multiple versions to create a safe financial environment that builds trust for both donors and researchers. That emphasis on security supports a system designed to move quickly without compromising reliability.

This approach arrives at a critical moment, as healthcare leaders continue to question where priorities lie. Society has demonstrated the ability to develop a COVID vaccine in less than a year, while also investing billions in space exploration and entertainment. Yet families still watch loved ones suffer from diseases that lack sufficient research momentum, raising difficult questions about what receives attention and funding.

A Call to Action for Healthcare Leaders

Curefundr addresses that imbalance by offering a direct path for cancer research donations to support early-stage ideas with the potential to save lives. The platform, accessible via their website, connects donors with researchers to make cancer research funding more immediate and transparent.

For healthcare business leaders, the opportunity is clear. By supporting new models of cancer research funding, you can help accelerate breakthroughs that might otherwise remain delayed. At the same time, researchers gain access to cancer research financing without the traditional bottlenecks that slow progress.

Cohan’s long-term vision is to make Curefundr the go-to platform for early-stage cancer research, reducing dependence on federal funding and empowering both donors and scientists. Ultimately, the question is not whether progress is possible, but whether the systems in place allow it to happen in time to matter.